热门资讯> 正文
预测肿瘤学宣布私募3.44亿美元
2025-09-29 21:40
- Predictive Oncology (NASDAQ:POAI) announced on Monday the pricing of two private placement transactions to support its adoption of a digital asset treasury strategy under which the principal holding will be ATH, the native utility token of the Aethir ecosystem.
- The company to raise an aggregate of approximately $344.4 million in two private investment in public equity transactions ((PIPEs)) for the purchase and sale of 66.7 million shares of common stock at $0.7751 per share for gross proceeds of $51.7 million and pre-funded warrants to purchase up to 223.6 million shares of common stock for a purchase price equal to the offering price minus $0.01 per pre-funded warrant in exchange for approximately $292.7 million in notional value representing $173.3 million in discounted value, of in-kind contributions of locked and unlocked Aethir tokens.
- The pre-funded warrants to be issued in the Crypto PIPE will become exercisable immediately following the company’s receipt of shareholder approval for the exercise of such pre-funded warrants.
- The PIPEs are expected to close concurrently on or about October 2, 2025.
- The company intends to use the in-kind contribution of ATH to fund the company’s digital asset treasury strategy and to use the remaining net proceeds from the PIPEs primarily to fund the acquisition of ATH in the open market in further support thereof, as well as for working capital and general corporate purposes.
- DNA Holdings Venture will serve as the company’s strategic advisor and consultant for the company’s digital asset treasury.
- POAI is +125.77% to $1.75.
- Source: Press Release
More on Predictive Oncology
- Predictive Oncology announces 1-for-15 reverse stock split
- Financial information for Predictive Oncology
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
